| |
| |
|
| Insider
Information: |
Berman Robert Andrew |
| Relationship: |
Chief Executive Office... |
| City: |
Newport Beach |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
301,789 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,489,086 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
301,789 |
|
|
| Total
Value |
$2,489,086 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -100.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acacia Research Corp |
ACTG |
COO, Genl Counsel, Sec... |
2007-02-09 |
30,000 |
2005-08-16 |
0 |
Premium* |
|
|
Anixa Biosciences Inc |
ANIX |
President & CEO, Direc... |
2017-06-02 |
61,553 |
2013-07-01 |
0 |
Premium* |
|
|
Envveno Medical Ord Shs |
NVNO |
Chief Executive Office... |
2022-06-27 |
210,236 |
2019-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACTG |
Acacia Research Corp |
Exec. V.P., Gen. Counsel, Sec. |
• – – |
2005-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
|
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2015-03-20 |
4 |
B |
$0.10 |
$5,020 |
D/D |
50,000 |
578,650 |
2.81 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2015-03-23 |
4 |
B |
$0.12 |
$6,085 |
D/D |
50,000 |
628,650 |
2.81 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2015-06-17 |
4 |
B |
$0.13 |
$6,745 |
D/D |
50,000 |
803,650 |
2.81 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2015-06-18 |
4 |
B |
$0.13 |
$6,485 |
D/D |
50,000 |
853,650 |
2.81 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2015-06-01 |
4 |
B |
$0.14 |
$4,269 |
D/D |
30,000 |
658,650 |
2.73 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2015-06-09 |
4 |
B |
$0.14 |
$1,399 |
D/D |
10,000 |
688,650 |
2.73 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2015-06-10 |
4 |
B |
$0.14 |
$1,449 |
D/D |
10,000 |
698,650 |
2.73 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2015-06-11 |
4 |
B |
$0.14 |
$3,558 |
D/D |
25,000 |
723,650 |
2.73 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2015-06-15 |
4 |
B |
$0.14 |
$4,080 |
D/D |
30,000 |
753,650 |
2.73 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2015-06-19 |
4 |
B |
$0.14 |
$2,800 |
D/D |
20,000 |
873,650 |
2.73 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2015-06-22 |
4 |
B |
$0.15 |
$9,024 |
D/D |
60,000 |
933,650 |
2.81 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2015-06-04 |
4 |
B |
$0.16 |
$3,250 |
D/D |
20,000 |
678,650 |
2.73 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2014-01-02 |
4 |
A |
$0.19 |
$1,000 |
D/D |
5,236 |
16,902 |
0 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2014-01-21 |
4 |
B |
$0.21 |
$5,243 |
D/D |
25,000 |
41,902 |
2.81 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2014-01-22 |
4 |
B |
$0.22 |
$10,120 |
D/D |
45,000 |
86,902 |
2.81 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2013-07-01 |
4 |
A |
$0.29 |
$1,000 |
D/D |
3,447 |
6,786 |
0 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2014-01-24 |
4 |
B |
$0.30 |
$2,524 |
D/D |
8,500 |
95,402 |
2.73 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2014-01-27 |
4 |
B |
$0.30 |
$12,053 |
D/D |
39,500 |
134,902 |
2.81 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2014-01-28 |
4 |
B |
$0.34 |
$7,069 |
D/D |
20,805 |
155,707 |
2.81 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President and CEO |
• • – |
2014-01-29 |
4 |
B |
$0.38 |
$4,793 |
D/D |
12,500 |
190,707 |
2.73 |
- |
|
| ANIX |
Anixa Biosciences Inc |
President & CEO |
• • – |
2017-06-02 |
4 |
B |
$0.85 |
$8,797 |
D/D |
10,000 |
61,553 |
2.81 |
- |
|
| NVNO |
Envveno Medical Ord Shs |
Chief Executive Officer |
• • – |
2019-03-12 |
4 |
B |
$1.15 |
$25,001 |
D/D |
21,740 |
21,740 |
2.81 |
- |
|
| NVNO |
Envveno Medical Ord Shs |
Chief Executive Officer |
• • – |
2019-03-12 |
4/A |
B |
$1.36 |
$25,000 |
D/D |
18,382 |
18,382 |
2.81 |
- |
|
| ACTG |
Acacia Research Corp |
COO, Gen. Counsel, Sec. |
• – – |
2006-04-26 |
4 |
OE |
$1.85 |
$101,750 |
D/D |
55,000 |
27,500 |
|
- |
|
48 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
